logo
Anti-thrombotic therapy in diabetic patients: revisited
The importance of managing diabetes correctly to prevent heart failure
Animal study data indicate that RevaTen platelet-rich plasma may be a promising treatment for heart attacks in the future
Review questions the prescription of statins in patients at low risk of cardiovascular disease
Atrial fibri llation recurrence more frequent in obese patients
Study reveals that candesartan has a lower risk of death than losartan in patients with heart failure
Allogenic stem cell injection for the treatment of critical limb ischemia to be evaluated in Phase II/III clinical trial
Protein interfering with blood clotting in the brain may increase stroke risk in diabetics
Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development
Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial
Cardiac arrhythmias: what's new? Report on the XIV International Symposium on Progress in Clinical Pacing
Pediatric cardiac intensive care
Cumulative effects of genetic risk variants on the development of common atherosclerosis
De-Toring high fat for a healthy heart
Cardiac manifestations of subarachnoid hemorrhage
Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East
Hepatic steatosis and Type 2 diabetes: current and future treatment considerations
Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization
Diabetic dyslipidemia or ‘diabetes lipidus’?
Do statins reduce the incidence of stroke in familial hypercholesterolemia?
Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism
Acute cardioembolic stroke: an update
Noninvasive imaging of prosthetic cardiac devices
Acknowledgements
Erratum